Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody-Reference-Cited by-同舟云学术

Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody

Published:2015-01 Issue:1-2 Volume:348 Page:67-73
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Kawagashira Yuichi,Koike Haruki,Ohyama Ken,Hashimoto Rina,Iijima Masahiro,Adachi Hiroaki,Katsuno Masahisa,Chapman Miles,Lunn Michael,Sobue Gen

Funder

Ministry of Health, Labour, and Welfare

Ministry of Education, Culture, Sports, Science, and Technology

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference49 articles.

1. Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics;Hafler;Neurology,1986

2. Peripheral neuropathy associated with monoclonal IgM autoantibody;Steck;Ann Neurol,1987

3. Peripheral neuropathy and anti-MAG antibodies;Latov;Crit Rev Neurobiol,1988

4. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study;Smith;Brain,1994

5. Neuropathy associated with “benign” anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases;Ellie;J Neurol,1996

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraproteinemia‐associated neuropathy with or without anti‐myelin‐associated glycoprotein antibody;Clinical and Experimental Neuroimmunology;2024-02-26

2. Anti-MAG Neuropathy;Reference Module in Neuroscience and Biobehavioral Psychology;2024

3. Anti–myelin‐associated glycoprotein neuropathy: Where do we stand?;Muscle & Nerve;2023-08-21

4. Polyneuropathy Associated with IgM Monoclonal Gammopathy; Advances in Genetics and Treatment, Focusing on Anti-MAG Antibodies;Hemato;2022-10-17

5. Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up;European Journal of Neurology;2022-09-25